SCISPARC LTD (SPRC) Stock News

NASDAQ:SPRC - IL0010951403 - Common Stock

2.41 USD

-0.05 (-2.03%)

Last: 9/2/2025, 1:56:35 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SPRC Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill - Mentions: CVM COO LPSN ASTI ...

News Image

Wondering what's happening in today's pre-market session?

4 days ago - By: Benzinga - Mentions: RMTI LIXT NEO CHEK ...

12 Health Care Stocks Moving In Friday's Intraday Session

5 days ago - By: Benzinga - Mentions: CVM MBRX CGC PAHC ...

12 Health Care Stocks Moving In Thursday's Intraday Session

5 days ago - By: SciSparc Ltd

SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

5 days ago - By: SciSparc Ltd

SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

5 days ago - By: SciSparc Ltd

SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel

5 days ago - By: SciSparc Ltd

SciSparc Shareholders Approve Merger with a Leading Parallel Vehicle Importer in Israel

a month ago - By: Clearmind Medicine Inc. - Mentions: CMND

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: SciSparc Ltd - Mentions: CMND -

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: SciSparc Ltd

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: SciSparc Ltd

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

a month ago - By: SciSparc Ltd

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

a month ago - By: Clearmind Medicine Inc. - Mentions: CMND

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

a month ago - By: SciSparc Ltd - Mentions: CMND

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

a month ago - By: SciSparc Ltd

SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification

a month ago - By: SciSparc Ltd

SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification

2 months ago - By: SciSparc Ltd

SciSparc Announces 1-for-21 Reverse Share Split

2 months ago - By: SciSparc Ltd

SciSparc Announces 1-for-21 Reverse Share Split

3 months ago - By: SciSparc Ltd

SciSparc Announces Publication of Japanese Patent Application

3 months ago - By: SciSparc Ltd

SciSparc Announces Publication of Japanese Patent Application

4 months ago - By: SciSparc Ltd

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

4 months ago - By: Clearmind Medicine Inc. - Mentions: CMND

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

4 months ago - By: SciSparc Ltd

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

4 months ago - By: SciSparc Ltd - Mentions: CMND

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

4 months ago - By: SciSparc Ltd

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

6 months ago - By: SciSparc Ltd

SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea